AJANTPHARM — Ajanta Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹396.95bn
- IN₹392.81bn
- IN₹54.53bn
Annual cashflow statement for Ajanta Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 9,095 | 7,453 | 11,139 | 11,892 | 13,777 |
| Depreciation | |||||
| Non-Cash Items | -332 | 5 | -520 | -320 | -96.8 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -4,395 | -848 | -4,122 | -1,440 | -10,119 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 5,620 | 7,918 | 7,851 | 11,572 | 5,292 |
| Capital Expenditures | -1,488 | -1,745 | -1,524 | -3,179 | -3,652 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 747 | -3,851 | 2,178 | -586 | -638 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -741 | -5,596 | 654 | -3,765 | -4,289 |
| Financing Cash Flow Items | -759 | -34.4 | -44.5 | -189 | -128 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -4,600 | -1,079 | -10,511 | -7,334 | -1,679 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 279 | 1,243 | -2,006 | 473 | -677 |